Exact Mass: 602.1394276000001

Exact Mass Matches: 602.1394276000001

Found 52 metabolites which its exact mass value is equals to given mass value 602.1394276000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Amaroswerin

[(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate

C29H30O14 (602.163548)


Amaroswerin is a member of biphenyls. Amaroswerin is a natural product found in Swertia japonica, Gentianella nitida, and other organisms with data available. Amaroswerin is a bioactive secoiridoid glucoside from Swertia mussotii. Amaroswerin has anti-inflammatory, antidiabetic, antiviral, anticholinergic and immunomodulatory activities. Amaroswerin inhibits NO release with an IC50?value of 5.42 μg/mL in?RAW264.7 cells[1]. Amaroswerin is a bioactive secoiridoid glucoside from Swertia mussotii. Amaroswerin has anti-inflammatory, antidiabetic, antiviral, anticholinergic and immunomodulatory activities. Amaroswerin inhibits NO release with an IC50?value of 5.42 μg/mL in?RAW264.7 cells[1].

   

Eriodictyol 7-(6-galloylglucoside)

(6-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3,4,5-trihydroxybenzoic acid

C28H26O15 (602.1271646)


Eriodictyol 7-(6-galloylglucoside) is found in fruits. Eriodictyol 7-(6-galloylglucoside) is a constituent of the leaves and branches of Phyllanthus emblica (emblic). Constituent of the leaves and branches of Phyllanthus emblica (emblic). Eriodictyol 7-(6-galloylglucoside) is found in fruits.

   

QUINOLONE DERIVATIVE

7-{4-[2-(4-chlorophenyl)-2-({[hydroxy(pyridin-4-yl)methylidene]amino}imino)ethyl]piperazin-1-yl}-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate

C31H28ClFN6O4 (602.184449)


   
   
   
   

(2S)-5,7,3,4-Tetrahydroxyflavanone 7-(6-galloylglucoside)

(2S)-5,7,3,4-Tetrahydroxyflavanone 7-(6-galloylglucoside)

C28H26O15 (602.1271646)


   
   

Lactranthospiren (?)

Lactranthospiren (?)

C39H22O7 (602.1365462)


   

(-)-epicatechin 3-O-beta-D-(3-O-vanillil)allopyranoside

(-)-epicatechin 3-O-beta-D-(3-O-vanillil)allopyranoside

C29H30O14 (602.163548)


   

lissoclibadin 2

lissoclibadin 2

C26H38N2O4S5 (602.1435028000001)


An organosulfur heterocyclic compound isolated from the ascidian Lissoclinum badium. It has been shown to exhibit cytotoxicity against human cancer cell lines.

   
   

6-O-p-Hydroxybenzoylcatalposide

6-O-p-Hydroxybenzoylcatalposide

C29H30O14 (602.163548)


   

3-hydroxy-4-O-beta-D-(6-O-vanilloylglucopyranosyl)benzyl vanilloate|litseaefoloside D

3-hydroxy-4-O-beta-D-(6-O-vanilloylglucopyranosyl)benzyl vanilloate|litseaefoloside D

C29H30O14 (602.163548)


   

(-)-epicatechin 3-O-beta-D-(2-O-vanillyl)allopyranoside

(-)-epicatechin 3-O-beta-D-(2-O-vanillyl)allopyranoside

C29H30O14 (602.163548)


   

3,5-dicaffeoyl-4-malonylquinic acid

3,5-dicaffeoyl-4-malonylquinic acid

C28H26O15 (602.1271646)


   
   

(S)-5,7,3,5-tetrahydroxyflavanone-7-O-(6-galloyl)-beta-D-glucopyranose

(S)-5,7,3,5-tetrahydroxyflavanone-7-O-(6-galloyl)-beta-D-glucopyranose

C28H26O15 (602.1271646)


   

1,2-dicaffeoyl-6-tuliposide A|1,2-O-dicaffeoyl-6-O-(4-hydroxy-2-methylenebutyroyl)-beta-D-glucopyranose

1,2-dicaffeoyl-6-tuliposide A|1,2-O-dicaffeoyl-6-O-(4-hydroxy-2-methylenebutyroyl)-beta-D-glucopyranose

C29H30O14 (602.163548)


   

1,4-dicaffeoyl-6-tuliposide A|1-O-caffeoyl-6-O-(4-caffeoyloxy-2-methylenebutyroyl)-beta-D-glucopyranose

1,4-dicaffeoyl-6-tuliposide A|1-O-caffeoyl-6-O-(4-caffeoyloxy-2-methylenebutyroyl)-beta-D-glucopyranose

C29H30O14 (602.163548)


   

myricetin 3-O-beta-D-(2-galloyl)arabinopyranoside

myricetin 3-O-beta-D-(2-galloyl)arabinopyranoside

C27H22O16 (602.0907812)


   
   

1-methoxyoxalyl-3,5-dicaffeoylquinic acid|1-MO-3,5-DCQA|1-O-methoxyoxaloyl-3,5-di-O-caffeoylquinic acid

1-methoxyoxalyl-3,5-dicaffeoylquinic acid|1-MO-3,5-DCQA|1-O-methoxyoxaloyl-3,5-di-O-caffeoylquinic acid

C28H26O15 (602.1271646)


   
   

Benzyl-4,5-di-O-methylhiascat

Benzyl-4,5-di-O-methylhiascat

C33H30O11 (602.178803)


   
   

(-)-2,3-digalloyl-4-(E)-caffeoyl-L-threonic acid

(-)-2,3-digalloyl-4-(E)-caffeoyl-L-threonic acid

C27H22O16 (602.0907812)


   
   

5-Carboxypyranocyanidin 3-O-(6-O-malonyl-beta-glucopyranoside)

5-Carboxypyranocyanidin 3-O-(6-O-malonyl-beta-glucopyranoside)

C27H22O16 (602.0907812)


   

[(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate

NCGC00385446-01![(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate

C29H30O14 (602.163548)


   

Eriodictyol 7-(6-galloylglucoside)

(6-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3,4,5-trihydroxybenzoate

C28H26O15 (602.1271646)


   

2,3,4,6-Tetra-O-benzyl-alpha-D-glucopyranosyl bromide

2,3,4,6-Tetra-O-benzyl-alpha-D-glucopyranosyl bromide

C34H35BrO5 (602.1667719999999)


   
   
   

1,3-diacetoxy-1,1,3,3-tetrabutyldistannoxane

1,3-diacetoxy-1,1,3,3-tetrabutyldistannoxane

C20H42O5Sn2 (602.1076062)


   

4-(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)-1-thiophen-2-ylpyrrolo[3,4-c]pyrrole-3,6-dione

4-(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)-1-thiophen-2-ylpyrrolo[3,4-c]pyrrole-3,6-dione

C30H39BrN2O2S2 (602.1636174)


   
   

2,4-Hexadiyne-1,6-diol Bis(azobenzene-4-sulfonate)

2,4-Hexadiyne-1,6-diol Bis(azobenzene-4-sulfonate)

C30H26N4O6S2 (602.1293696)


   

2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl bromide

2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl bromide

C34H35BrO5 (602.1667719999999)


   

AVE 0991 sodium salt

AVE 0991 sodium salt

C29H31N4NaO5S2 (602.1633476000001)


AVE 0991 sodium salt is a nonpeptide and orally active Ang-(1-7) receptor Mas agonist. AVE 0991 competes for high-affinity binding of [125I]-Ang-(1-7) to bovine aortic endothelial cell membranes with IC50 of 21 nM[1].

   

Ceftazidime t-Butyl Ester

Ceftazidime t-Butyl Ester

C26H30N6O7S2 (602.161731)


   

{4-[(2S,4E)-2-(1,3-Benzothiazol-2-YL)-2-(1H-1,2,3-benzotriazol-1-YL)-5-phenylpent-4-enyl]phenyl}(difluoro)methylphosphonic acid

{4-[(2S,4E)-2-(1,3-Benzothiazol-2-YL)-2-(1H-1,2,3-benzotriazol-1-YL)-5-phenylpent-4-enyl]phenyl}(difluoro)methylphosphonic acid

C31H25F2N4O3PS (602.1352973999999)


   

Amoxicillin and clavulanate potassium

Amoxicillin and clavulanate potassium

C24H27KN4O10S (602.1084902)


   

(2S)-eriodictyol 7-O-(6-O-galloyl)-beta-D-glucopyranoside

(2S)-eriodictyol 7-O-(6-O-galloyl)-beta-D-glucopyranoside

C28H26O15 (602.1271646)


A monosaccharide derivative that is eriodictyol attached to a (6-O-galloyl)-beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage.

   

pelargonidin 3-O-(3,6-O-dimalonyl-beta-glucopyranoside

pelargonidin 3-O-(3,6-O-dimalonyl-beta-glucopyranoside

C27H22O16-2 (602.0907812)


   

7-[4-[(2E)-2-(4-chlorophenyl)-2-(pyridine-4-carbonylhydrazinylidene)ethyl]piperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid

7-[4-[(2E)-2-(4-chlorophenyl)-2-(pyridine-4-carbonylhydrazinylidene)ethyl]piperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid

C31H28ClFN6O4 (602.184449)


   

6-[(2S,3R,4S,5S,6R)-6-[(2-carboxyacetyl)oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-7-(3,4-dihydroxyphenyl)-11-oxo-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid

6-[(2S,3R,4S,5S,6R)-6-[(2-carboxyacetyl)oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-7-(3,4-dihydroxyphenyl)-11-oxo-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid

C27H22O16 (602.0907812)


   

1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

C30H33Cl2FN4O4 (602.186277)


   

1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

C30H33Cl2FN4O4 (602.186277)


   

6-[(2S,5S,6R)-6-[(2-carboxyacetyl)oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-7-(3,4-dihydroxyphenyl)-11-oxo-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid

6-[(2S,5S,6R)-6-[(2-carboxyacetyl)oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-7-(3,4-dihydroxyphenyl)-11-oxo-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid

C27H22O16 (602.0907812)